BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11535875)

  • 21. A prospective study of aspirin use and the risk for colorectal adenoma.
    Chan AT; Giovannucci EL; Schernhammer ES; Colditz GA; Hunter DJ; Willett WC; Fuchs CS
    Ann Intern Med; 2004 Feb; 140(3):157-66. PubMed ID: 14757613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Difluoromethylornithine and Aspirin for Treatment of Adenomas and Aberrant Crypt Foci in Patients with Prior Advanced Colorectal Neoplasms.
    Sinicrope FA; Velamala PR; Song LMWK; Viggiano TR; Bruining DH; Rajan E; Gostout CJ; Kraichely RE; Buttar NS; Schroeder KW; Kisiel JB; Larson MV; Sweetser SR; Sedlack RR; Sinicrope SN; Richmond E; Umar A; Della'Zanna G; Noaeill JS; Meyers JP; Foster NR
    Cancer Prev Res (Phila); 2019 Nov; 12(11):821-830. PubMed ID: 31484660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
    Baron JA; Sandler RS; Bresalier RS; Quan H; Riddell R; Lanas A; Bolognese JA; Oxenius B; Horgan K; Loftus S; Morton DG;
    Gastroenterology; 2006 Dec; 131(6):1674-82. PubMed ID: 17087947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network.
    Alberts DS; Martínez ME; Roe DJ; Guillén-Rodríguez JM; Marshall JR; van Leeuwen JB; Reid ME; Ritenbaugh C; Vargas PA; Bhattacharyya AB; Earnest DL; Sampliner RE
    N Engl J Med; 2000 Apr; 342(16):1156-62. PubMed ID: 10770980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
    Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
    J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group.
    Baron JA; Beach M; Mandel JS; van Stolk RU; Haile RW; Sandler RS; Rothstein R; Summers RW; Snover DC; Beck GJ; Bond JH; Greenberg ER
    N Engl J Med; 1999 Jan; 340(2):101-7. PubMed ID: 9887161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meat intake and the recurrence of colorectal adenomas.
    Mathew A; Sinha R; Burt R; Caan B; Paskett E; Iber F; Kikendall W; Lance P; Shike M; Weissfeld J; Schatzkin A; Lanza E;
    Eur J Cancer Prev; 2004 Jun; 13(3):159-64. PubMed ID: 15167213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of chemoprevention by low-dose aspirin of new or recurrent colorectal adenomas in patients with Lynch syndrome (AAS-Lynch): study protocol for a multicenter, double-blind, placebo-controlled randomized controlled trial.
    Soualy A; Deutsch D; Benallaoua M; Ait-Omar A; Mary F; Helfen S; Boubaya M; Levy V; Benamouzig R;
    Trials; 2020 Sep; 21(1):764. PubMed ID: 32887653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.
    Benamouzig R; Uzzan B; Little J; Chaussade S
    Curr Top Med Chem; 2005; 5(5):493-503. PubMed ID: 15974944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Celecoxib for the prevention of colorectal adenomatous polyps.
    Arber N; Eagle CJ; Spicak J; Rácz I; Dite P; Hajer J; Zavoral M; Lechuga MJ; Gerletti P; Tang J; Rosenstein RB; Macdonald K; Bhadra P; Fowler R; Wittes J; Zauber AG; Solomon SD; Levin B;
    N Engl J Med; 2006 Aug; 355(9):885-95. PubMed ID: 16943401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenoma recurrences after resection of colorectal carcinoma: results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study.
    Chu DZ; Chansky K; Alberts DS; Meyskens FL; Fenoglio-Preiser CM; Rivkin SE; Mills GM; Giguere JK; Goodman GE; Abbruzzese JL; Lippman SM
    Ann Surg Oncol; 2003 Oct; 10(8):870-5. PubMed ID: 14527904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
    Cole BF; Baron JA; Sandler RS; Haile RW; Ahnen DJ; Bresalier RS; McKeown-Eyssen G; Summers RW; Rothstein RI; Burke CA; Snover DC; Church TR; Allen JI; Robertson DJ; Beck GJ; Bond JH; Byers T; Mandel JS; Mott LA; Pearson LH; Barry EL; Rees JR; Marcon N; Saibil F; Ueland PM; Greenberg ER;
    JAMA; 2007 Jun; 297(21):2351-9. PubMed ID: 17551129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.
    Grau MV; Baron JA; Barry EL; Sandler RS; Haile RW; Mandel JS; Cole BF
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2353-8. PubMed ID: 16214916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population.
    Stingl JC; Ettrich T; Muche R; Wiedom M; Brockmöller J; Seeringer A; Seufferlein T
    BMC Cancer; 2011 Aug; 11():360. PubMed ID: 21851602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.
    Alberts DS; Martínez ME; Hess LM; Einspahr JG; Green SB; Bhattacharyya AK; Guillen J; Krutzsch M; Batta AK; Salen G; Fales L; Koonce K; Parish D; Clouser M; Roe D; Lance P;
    J Natl Cancer Inst; 2005 Jun; 97(11):846-53. PubMed ID: 15928305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.
    Huls G; Koornstra JJ; Kleibeuker JH
    Lancet; 2003 Jul; 362(9379):230-2. PubMed ID: 12885487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group.
    Bonithon-Kopp C; Kronborg O; Giacosa A; Räth U; Faivre J
    Lancet; 2000 Oct; 356(9238):1300-6. PubMed ID: 11073017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years.
    Laiyemo AO; Murphy G; Albert PS; Sansbury LB; Wang Z; Cross AJ; Marcus PM; Caan B; Marshall JR; Lance P; Paskett ED; Weissfeld J; Slattery ML; Burt R; Iber F; Shike M; Kikendall JW; Lanza E; Schatzkin A
    Ann Intern Med; 2008 Mar; 148(6):419-26. PubMed ID: 18347350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced age is a risk factor for proximal adenoma recurrence following colonoscopy and polypectomy.
    Pommergaard HC; Burcharth J; Rosenberg J; Raskov H
    Br J Surg; 2016 Jan; 103(2):e100-5. PubMed ID: 26667088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials.
    Veettil SK; Lim KG; Ching SM; Saokaew S; Phisalprapa P; Chaiyakunapruk N
    BMC Cancer; 2017 Nov; 17(1):763. PubMed ID: 29137605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.